Phillips-Medisize, a medical injection molder, bought Denmark’s Medicom Innovation Partner, a provider of device strategy, product design and drug delivery systems, in a move to expand its footprint in Europe. Terms of the deal weren’t disclosed.
With the acquisition, Phillips-Medisize will have more than 500 engineers globally, the company said. The combined companies now have facilities in Hudson, WI; Mountain View, CA; Hillegom, Netherlands; Struer, Denmark; Cambridge, U.K.; and Suzhou, China.
By adding Medicom to its mix, Phillips-Medisize grows its end-to-end injectable and inhalation device and services offerings as well as providing an opportunity to leverage Medicom’s tech accelerator programs and early device development strategy systems.
Medicom, which has about 90 employees in Denmark and the U.K., was founded in 1989 as a venture by the audio company Bang & Olufsen.
“This transaction is consistent with our strategic focus on serving the rapidly growing diabetes, biologics, specialty pharmaceutical and personalized oncology markets that need these products and reinforces our leading position in drug delivery device solutions,” Matt Jennings, chairman and CEO of Phillips-Medisize, said in a statement.
In 2007, Danish private equity investor Maj Invest Equity bought a 65% majority stake in Medicom.
- here’s the release
Spanish sterile injectable player gets snapped up